The Centers for Medicare & Medicaid Services (CMS) is implementing 2 new procedure codes, in addition to the 7 new procedure codes announced in November 2021, bringing the total to 9 new procedure codes, to describe the introduction or infusion of therapeutics, including vaccines for COVID-19 treatment, into the International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS), effective April 1, 2022.
At the national level, adding social needs data to hospital claims enables system-wide research to gain a better understanding of the health-related social needs of patients and communities around the country. Federal programs could be tailored to meet those needs. Furthermore, as payment moves from volume to value, having claims data connected to social needs can support policy and payment reforms, including appropriate risk-adjustments.
The 2 new ICD-10-PCS codes are:
- XW023X7 – Introduction of tixagevimab and cilgavimab monoclonal antibody into muscle, percutaneous approach, new technology group 7
- XW023Y7 – Introduction of other new technology monoclonal antibody into muscle, percutaneous approach, new technology group 7
Source: U.S. Centers for Medicare & Medicaid Services (CMS)
About 3Gen
3Gen Consulting has always been in the forefront when it comes to adding value. We always believe in setting our own standards. What sets us apart is the investment that we make in our people, processes and innovation to provide you with market leading healthcare revenue cycle management services. We work as an extension of our clients’ teams by focusing on their key challenges, aligning with their culture and delivering the best results.
If you’re interested in finding the right medical billing and coding services partner, contact us today.
